Upregulation of 78‐kDa glucose‐regulated protein in macrophages in peripheral joints of active ankylosing spondylitis

References

• Davis J. C. Ankylosing spondylitis. Arthritis and allied conditions: a textbook of rheumatology, W. J Koopman, L. W Moreland. Lippincott, Williams and Wilkins, Philadelphia 2005; 1319–34, 15th edn
   Google Scholar
• Braun J., Baraliakos X., Godolias G., Bohm H. Therapy of ankylosing spondylitis – a review. Part I: Conventional medical treatment and surgical therapy. Scand J Rheumatol 2005; 34: 97–108
   PubMed Web of Science ®Google Scholar
• Rycke L. D., Kruithof E., Vandooren B., Tak P. P., Baeten D. Pathogenesis of spondyloarthritis: insights from synovial membrane studies. Curr Rheumatol Rep 2006; 8: 275–82
   PubMedGoogle Scholar
• Baeten D., De Keyser F. The histopathology of spondyloarthropathy. Curr Mol Med 2004; 4: 1–12
   PubMed Web of Science ®Google Scholar
• Lopez de Castro J. A. HLA‐B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 2007; 108: 27–33
   PubMed Web of Science ®Google Scholar
• Mear J. P., Schreiber K. L., Munz C., Zhu X., Stevanovic S., Rammensee H. S., et al. Misfolding of HLA‐B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999; 163: 6665–70
   PubMed Web of Science ®Google Scholar
• Dangoria N. S., DeLay M. L., Kingsbury D. J., Mear J. P., Uchanska‐Ziegler B., Ziegler A., et al. HLA‐B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002; 277: 23459–68
   PubMed Web of Science ®Google Scholar
• Turner M. J., Sowders D. P., DeLay M. L., Mohapatra R., Bai S., Smith J. A., et al. HLA‐B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175: 2438–48
   PubMed Web of Science ®Google Scholar
• Yu D. T. Pathogenesis and biomarkers in spondyloarthritis: clues from microarray analyses. Curr Rheumatol Rev 2006; 2: 215–18
   Google Scholar
• Pahl H. L., Baeuerle P. A. The ER‐overload response: activation of NF‐κB. Trends Biochem Sci 1997; 22: 63–7
   PubMed Web of Science ®Google Scholar
• Tran T. M., Satumtira N., Dorris M. L., May E., Wang A., Furuta E., et al. HLA‐B27 in transgenic rats forms disulfide‐linked heavy chain oligomers and multimers that bind to the chaperone BiP. J Immunol 2004; 172: 5110–19
   PubMed Web of Science ®Google Scholar
• Turner M. J., DeLay M. L., Bai S., Klenk E., Colbert R. A. HLA‐B27 up‐regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats. Arthritis Rheum 2007; 56: 215–23
   PubMed Web of Science ®Google Scholar
• Gu J., Rihl M., Märker‐Hermann E., Baeten D., Kuipers J. G., Song Y. W., et al. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol 2002; 29: 2159–64
   PubMed Web of Science ®Google Scholar
• Lee A. S. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods 2005; 35: 373–81
   PubMed Web of Science ®Google Scholar
• van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–8
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
   PubMed Web of Science ®Google Scholar
• Calin A., Nakache J. P., Gueguen A., Zeidler H., Mielants H., Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?. Rheumatol 1999; 38: 878–82
   PubMed Web of Science ®Google Scholar
• Li J., Lee A. S. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 2006; 6: 45–54
   PubMed Web of Science ®Google Scholar
• Bernales S., Papa F. R., Walter P. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol 2006; 22: 487–508
   PubMed Web of Science ®Google Scholar
• De Benedetti F. Measurement of cytokines in synovial fluid. Interleukin protocols, L. A. J O'Neill, A Bowie. Humana Press, Totowa, NJ 2001; 327–35
   Google Scholar
• Colbert R. A. HLA‐B27 misfolding: a solution to the spondyloarthropathy conundrum?. Mol Med Today 2000; 6: 224–30
   PubMedGoogle Scholar
• Smith J. A., Marker‐Hermann E., Colbert R. A. Pathogenesis of ankylosing spondylitis: current concepts. Best Prac Res Clin Rheumatol 2006; 571–91
   PubMed Web of Science ®Google Scholar
• Gabay C. Interleukin‐6 and chronic inflammation. Arthritis Res Ther 2006; 8((Suppl 2))S3
   PubMed Web of Science ®Google Scholar
• Davis J. C., Mease P. J. Insights into the pathology and treatment of spondyloarthritis: from the bench to the clinic. Semin Arthritis Rheum 2008, doi: 10.1016/j.semarthrit.2007.10.007
   Web of Science ®Google Scholar
• Gratacos J., Collado A., Filella X., Sanmarti R., Canete J., Llena J., et al. Serum cytokines (IL‐6, TNF‐α, IL‐1β and IFN‐γ) in ankylosing spondylitis: a close correlation between serum IL‐6 and disease activity and severity. Br J Rheumatol 1994; 33: 927–31
   PubMedGoogle Scholar
• Park M. C., Lee S. W., Choi S. T., Park Y. B., Lee S. K. Serum leptin levels correlate with interleukin‐6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 2007; 36: 101–6
   PubMed Web of Science ®Google Scholar
• Claudepierre P., Rymer J. C., Authier F. J., Allanore Y., Larget‐Piet B., Gherardi R., et al. A relationship between TGF‐β or IL‐6 plasma levels and clinical features of spondyloarthropathies. Br J Rheumatol 1997; 36: 400–1
   PubMedGoogle Scholar
• Kruithof E., De Rycke L., Vandooren B., De Keyser F., FitzGerald O., McInnes I., et al. Identification of synovial biomarkers of response to experimental treatment in early‐phase clinical trials in spondyloarthritis. Arthritis Rheum 2006; 54: 1795–804
   PubMed Web of Science ®Google Scholar
• Baeten D., Kruithof E., Rycke L. D., Boots A. M., Mielants H., Veys E. M., et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects systemic disease activity in spondyloarthropathy. Arthritis Res Ther 2005; 7: R359–68
   PubMed Web of Science ®Google Scholar
• Na K. S., Kim T. H. Biomarkers in spondyloarthritis. Curr Rheumatol Rep 2006; 8: 283–6
   PubMedGoogle Scholar